Hormonal
GLP-1 receptor agonists (GLP-1RAs) are perceived by primary care providers as effective and promising tools for managing recurrent weight gain after metabolic bariatric surgery (MBS), offering renewed optimism and life-changing results for patients.
If you have had bariatric surgery and are regaining weight, GLP-1 medications like semaglutide are a viable and effective option to help you lose weight again. However, they are not a magic bullet; you must continue to focus on diet and exercise. The main barrier is cost, so work with your provider to navigate insurance coverage or assistance programs.
PCPs perceived GLP-1RAs as a promising and effective tool for addressing recurrent weight gain after MBS, and that care options for patients had improved.
Why this rating
Evidence is based on qualitative provider perspectives and emerging short-term reviews, not long-term randomized controlled trials in this specific population.
Source
Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery – a Qualitative Study
Liisa Tolvanen et al. · Obesity Surgery · 2025
DOI 10.1007/s11695-025-08408-0
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →